• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Whitepaper: Expedite development while ensuring successful commercial outcomes

28 February 2013  •  Author(s): Darren Hassey, Director, Quality Assurance, AMRI

AMRI LogoAs regulatory expectations continue to evolve in the area of pharmaceutical development, working with contract research and manufacturing organizations (CRMOs) that couple execution experience with high-end technical capabilities and contemporary quality systems will ensure the most value from strategic partnerships and enhance a project’s progress on its path toward commercialization.

The rest of this content is restricted to logged-in subscribers. Login or register (it's free!) to view the full content.

Leave a reply

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +